Amgen (AMGN) PT Lowered to $216 at RBC Capital

November 3, 2021 6:11 AM

RBC Capital analyst Kennen MacKay lowered the price target on Amgen (NASDAQ: AMGN) to $216.00 (from $217.00) while maintaining a Sector Perform rating.

No results found